- Home
- TXG vs MFIC Comparison
TXG vs MFIC Comparison
Compare TXG & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- MFIC
- Stock Information
- Founded
- TXG 2012
- MFIC 2004
- Country
- TXG United States
- MFIC United States
- Employees
- TXG N/A
- MFIC N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- MFIC Finance/Investors Services
- Sector
- TXG Industrials
- MFIC Finance
- Exchange
- TXG Nasdaq
- MFIC Nasdaq
- Market Cap
- TXG 1.5B
- MFIC 1.4B
- IPO Year
- TXG 2019
- MFIC 2004
- Fundamental
- Price
- TXG $10.90
- MFIC $14.60
- Analyst Decision
- TXG Buy
- MFIC Buy
- Analyst Count
- TXG 16
- MFIC 7
- Target Price
- TXG $20.36
- MFIC $14.67
- AVG Volume (30 Days)
- TXG 2.9M
- MFIC 302.7K
- Earning Date
- TXG 02-12-2025
- MFIC 02-25-2025
- Dividend Yield
- TXG N/A
- MFIC 10.41%
- EPS Growth
- TXG N/A
- MFIC 14.94
- EPS
- TXG N/A
- MFIC 1.53
- Revenue
- TXG $610,785,000.00
- MFIC $291,576,000.00
- Revenue This Year
- TXG $4.38
- MFIC $12.92
- Revenue Next Year
- TXG $9.08
- MFIC $17.11
- P/E Ratio
- TXG N/A
- MFIC $9.57
- Revenue Growth
- TXG N/A
- MFIC 8.84
- 52 Week Low
- TXG $10.80
- MFIC $12.26
- 52 Week High
- TXG $48.42
- MFIC $16.36
- Technical
- Relative Strength Index (RSI)
- TXG 24.63
- MFIC 72.87
- Support Level
- TXG $11.43
- MFIC $13.99
- Resistance Level
- TXG $13.12
- MFIC $14.74
- Average True Range (ATR)
- TXG 0.98
- MFIC 0.16
- MACD
- TXG -0.24
- MFIC 0.05
- Stochastic Oscillator
- TXG 2.27
- MFIC 86.27
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
About MFIC MidCap Financial Investment Corporation
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.